Skip to main content

EDITORIAL article

Front. Genet.
Sec. RNA
Volume 15 - 2024 | doi: 10.3389/fgene.2024.1461574
This article is part of the Research Topic RNA-Chromatin Interactions: Biology, Mechanism, Disease and Therapeutics - Volume 2 View all 5 articles

Editorial: RNA-Chromatin Interactions: Biology, Mechanism, Disease, and Therapeutics -Volume 2

Provisionally accepted
  • 1 Department of Cell Biology and Anatomy, Physiology, New York Medical College, Valhalla, New York, United States
  • 2 Adelaide Centre for Epigenetics, South Australian Immunogenomics Cancer Institute, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia
  • 3 Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
  • 4 Benthos Prime Central, Houston, United States

The final, formatted version of the article will be published soon.

    Keywords: noncoding RNA, RNA, chromatin RNA, long noncoding RNA, epigenetics, miRNA, Epitranscriptomics

    Received: 08 Jul 2024; Accepted: 15 Jul 2024.

    Copyright: © 2024 Bisserier, Martelotto, El-Osta and Mathiyalagan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Prabhu Mathiyalagan, Benthos Prime Central, Houston, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.